Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2016-11-08
2017-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Detection of Glaucoma Using Pupillography
NCT01462526
Glaucoma Screening With Smartphone Ophthalmology
NCT02520674
Correlation of Structure and Function in Glaucoma
NCT05954637
Evaluation of Corneal Temperature by Infrared Thermography in Glaucoma Patients
NCT02674074
Community Glaucoma Screening Follow-up
NCT00956865
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Glaucoma
Patients with a diagnosis of glaucoma will undergo color vision test
Color Vision Test
Farnsworth Panel D15/Hue test plus Ishihara charts
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Color Vision Test
Farnsworth Panel D15/Hue test plus Ishihara charts
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age between 18 and 99 years old
* best corrected visual acuity(BCVA) \> 0.2 (decimal Snellen)
Exclusion Criteria
* BCVA \< 0.2
* known dyschromatopsia
* known corneal disease
* St.p. corneal surgeries
* macula disease
* history of medication use that can influence color vision (e.g. hydroxychloroquine)
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jens Funk, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
UniversityHospital Zurich, Dept. of Ophthalmology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dyschromatopsia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.